CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Retinal Degeneration

retrosense

RetroSense Therapeutics Completes pre-IND Meeting for RST-001

RetroSense Therapeutics, a gene therapy company dedicated to vision restoration, announced completion of a pre-IND meeting with the Center for Biological Evaluation and Research division of the FDA that took place on May 22 regarding RetroSense’s lead product candidate, RST-001 for vision restoration in retinal degenerative conditions.

WWJ Newsradio 950–05/24/2012

Follow

Get every new post delivered to your Inbox.

Join 1,870 other followers